Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)

N Katsumata, T Watanabe, H Minami, K Aogi, T Tabei, M Sano, N Masuda, J Andoh, T Ikeda, T Shibata and S. Takashima

Annals of Oncology 20 ( 7 ): 1210 - 1215 , 2009